DIS
62
2
STZ
58
3
CHD
48
-3
BLK
70
-2
XEL
65
-2
FOX
57
-3
ALLE
41
-7
TXT
62
2
PG
50
2
NRG
50
-2
C
62
-3
LRCX
46
-2
DRI
56
2
HSY
43
3
TAP
64
4
PWR
71
-3
LNC
45
-4
NI
73
3
CVX
38
6
CMI
67
4
DIS
62
2
STZ
58
3
CHD
48
-3
BLK
70
-2
XEL
65
-2
FOX
57
-3
ALLE
41
-7
TXT
62
2
PG
50
2
NRG
50
-2
C
62
-3
LRCX
46
-2
DRI
56
2
HSY
43
3
TAP
64
4
PWR
71
-3
LNC
45
-4
NI
73
3
CVX
38
6
CMI
67
4
Financhill
Back

Addex Therapeutics 10K Form

Sell
21

ADXN
Addex Therapeutics

Last Price:
8.30
Seasonality Move:
34.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADXN News And Ratings

See the #1 stock for the next 7 days that we like better than ADXN

ADXN Financial Statistics

Sales & Book Value

Annual Sales: $1.8M
Cash Flow: $-2.96M
Price / Cash Flow: 0
Annual Sales: $13.17
Price / Book: 0.66

Profitability

EPS (TTM): -1.64250
Net Income (TTM): $4.52M
Gross Margin: $2.55M
Return on Equity: 90.28%
Return on Assets: 54.9%

Addex Therapeutics Earnings Forecast

Key Addex Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 8 years for ADXN is 91.70%.
  • The Selling, General & Administrative Expenses for ADXN have been equal to 446.69% of Gross Profit Margin.
  • The Research & Development expenses have been 170.40% of Revenue.
  • The Interest Expense is -0.20% of Operating Income.
  • The Net Earning history of ADXN is -654.47% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 13 years.

Addex Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADXN
Website: addextherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.97
Quick Ratio: 4.67

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADXN Technical Analysis vs Fundamental Analysis

Sell
21
Addex Therapeutics (ADXN) is a Sell

Is Addex Therapeutics a Buy or a Sell?